Article
Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.
Molecular genetics and metabolism - 1 Dec 1999
Gatti R A, Tward A, Concannon P
Abstract excerpt
The failure to find an increased frequency of ATM mutations in large cancer cohorts, especially breast cancer, is contrary to what was anticipated based on the increased cancer susceptibility of obligate ATM heterozygotes from families with ataxia-telangiectasia (A-T). We hypothesize that this paradox might be resolved if two types of ATM heterozygotes exist and the phenotypes differ, i.e., those with truncating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
